
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper... Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.12 | 5 | 2.4 | 2.57 | 2.4 | 77164 | 2.48206423 | CS |
4 | 0.09 | 3.7037037037 | 2.43 | 2.57 | 2.33 | 95266 | 2.42621616 | CS |
12 | -0.04 | -1.5625 | 2.56 | 2.73 | 2.33 | 174485 | 2.53107759 | CS |
26 | 0.62 | 32.6315789474 | 1.9 | 3 | 1.84 | 472203 | 2.45763352 | CS |
52 | -23.83 | -90.4364326376 | 26.35 | 32.415 | 1.25 | 575406 | 4.07399884 | CS |
156 | -9.78 | -79.512195122 | 12.3 | 32.415 | 1.25 | 252288 | 7.6052128 | CS |
260 | -25.48 | -91 | 28 | 32.415 | 1.25 | 223873 | 8.3211332 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관